319 related articles for article (PubMed ID: 25946000)
1. Drug repositioning for diabetes based on 'omics' data mining.
Zhang M; Luo H; Xi Z; Rogaeva E
PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
[TBL] [Abstract][Full Text] [Related]
2. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
3. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
4. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug indications based on chemical interactions and chemical similarities.
Huang G; Lu Y; Lu C; Zheng M; Cai YD
Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
[TBL] [Abstract][Full Text] [Related]
6. Pathway analysis for drug repositioning based on public database mining.
Pan Y; Cheng T; Wang Y; Bryant SH
J Chem Inf Model; 2014 Feb; 54(2):407-18. PubMed ID: 24460210
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
8. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
Zheng H
Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
[TBL] [Abstract][Full Text] [Related]
9. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.
Khosravi A; Jayaram B; Goliaei B; Masoudi-Nejad A
Mol Med; 2019 Jun; 25(1):30. PubMed ID: 31221082
[TBL] [Abstract][Full Text] [Related]
10. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
11. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
12. EK-DRD: A Comprehensive Database for Drug Repositioning Inspired by Experimental Knowledge.
Zhao C; Dai X; Li Y; Guo Q; Zhang J; Zhang X; Wang L
J Chem Inf Model; 2019 Sep; 59(9):3619-3624. PubMed ID: 31433187
[TBL] [Abstract][Full Text] [Related]
13. Molecular property diagnostic suite for diabetes mellitus (MPDS
Gaur AS; Nagamani S; Tanneeru K; Druzhilovskiy D; Rudik A; Poroikov V; Narahari Sastry G
J Biomed Inform; 2018 Sep; 85():114-125. PubMed ID: 30092360
[TBL] [Abstract][Full Text] [Related]
14. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
15. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
16. Exploring the associations between drug side-effects and therapeutic indications.
Wang F; Zhang P; Cao N; Hu J; Sorrentino R
J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
[TBL] [Abstract][Full Text] [Related]
17. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
Wang YY; Cui C; Qi L; Yan H; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
[TBL] [Abstract][Full Text] [Related]
18. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
Wang H; Gu Q; Wei J; Cao Z; Liu Q
Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
Sun P; Guo J; Winnenburg R; Baumbach J
Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
